455 North Bernardo Avenue
Mountain View, CA 94043
United States
650-237-2700
https://www.neuropace.com
Settore/i: Healthcare
Settore: Medical Devices
Impiegati a tempo pieno: 181
Nome | Titolo | Retribuzione | Esercitate | Anno di nascita |
---|---|---|---|---|
Mr. Joel D. Becker | CEO, President & Director | 762k | N/D | 1968 |
Ms. Rebecca L. Kuhn | CFO, VP of Finance & Administration, Corporate Secretary and Assistant Secretary | 614,91k | N/D | 1961 |
Dr. Martha J. Morrell | Chief Medical Officer | 728,68k | N/D | 1957 |
Mr. Dylan St. John | Chief of Operations & Development | N/D | N/D | N/D |
Ms. Leah Akin | Acting General Counsel | N/D | N/D | N/D |
Ms. Kelley Nicholas | Vice President of Sales | N/D | N/D | N/D |
NeuroPace, Inc. operates as a medical device company in the United States. The company develops RNS system, a brain-responsive neuromodulation system that delivers personalized, real-time treatment at the seizure source for treating medically refractory focal epilepsy. It also records continuous brain activity data and enables clinicians to monitor patients in person and remotely. Its RNS System includes RNS neurostimulator, cortical strip and depth leads, and Patient Remote Monitor, as well as other implantable and non-implantable accessories. The company sells its products to hospital facilities for initial RNS system implant procedures and for replacement procedures. NeuroPace, Inc. was incorporated in 1997 and is headquartered in Mountain View, California.
L'ISS Governance QualityScore di NeuroPace, Inc. al N/D è N/D. I criteri di valutazione fondamentali sono revisione: N/D; Consiglio di Amministrazione: N/D; diritti degli azionisti: N/D; retribuzione: N/D.